Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wesley

Showing results (301-310 of 354) with videos related to

Pageof 36
Sort By:
The Journal of Allergy and Clinical Immunology|August 24, 2023
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy developmentYoojin Chun, Alexander Grishin, Rebecca Rose, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2021
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trialsKari R Brown, James Baker, Andrea Vereda, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2013
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparisonStacy J Chin, Brian P Vickery, Michael D Kulis, et al.
Allergy|September 12, 2022
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humansDaniel Lozano-Ojalvo, Scott R Tyler, Carlos J Aranda, et al.
The Journal of Clinical Investigation|March 19, 2019
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana Rk Murthy, Niamh X Cawley, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2015
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialA Wesley Burks, Robert A Wood, Stacie M Jones, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
Frontiers in Microbiology|October 13, 2022
Soil-atmosphere fluxes of CO<sub>2</sub>, CH<sub>4</sub>, and N<sub>2</sub>O across an experimentally-grown, successional gradient of biocrust community typesAndrew D Richardson, Gary V Kong, Katrina M Taylor, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trialDavid M Fleischer, A Wesley Burks, Brian P Vickery, et al.
Pageof 36

Showing results (301-310 of 354) with videos related to

Sort By:
Pageof 36
The Journal of Allergy and Clinical Immunology|August 24, 2023
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy developmentYoojin Chun, Alexander Grishin, Rebecca Rose, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2021
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trialsKari R Brown, James Baker, Andrea Vereda, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2013
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparisonStacy J Chin, Brian P Vickery, Michael D Kulis, et al.
Allergy|September 12, 2022
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humansDaniel Lozano-Ojalvo, Scott R Tyler, Carlos J Aranda, et al.
The Journal of Clinical Investigation|March 19, 2019
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana Rk Murthy, Niamh X Cawley, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2015
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialA Wesley Burks, Robert A Wood, Stacie M Jones, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocolEdwin H Kim, Stacie M Jones, A Wesley Burks, et al.
Frontiers in Microbiology|October 13, 2022
Soil-atmosphere fluxes of CO<sub>2</sub>, CH<sub>4</sub>, and N<sub>2</sub>O across an experimentally-grown, successional gradient of biocrust community typesAndrew D Richardson, Gary V Kong, Katrina M Taylor, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trialDavid M Fleischer, A Wesley Burks, Brian P Vickery, et al.
Pageof 36